Research Topics
| G RoncoSummaryAffiliation: CPO Piemonte Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activityGuglielmo Ronco
CPO Piemonte, Torino
Epidemiol Prev 33:41-56. 2009..0%. The unadjusted detection rate of CIN2 or more severe histology was 2.9 per 1,000 screened women (3.1 standardised on the Italian population, truncated 25-64)...
[Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity]Guglielmo Ronco
CPO Piemonte, Torino
Epidemiol Prev 36:39-54. 2012..0%. The unadjusted detection rate of CIN2 or more severe histology was 3.2 per 1,000 screened women (3.5 standardised on the Italian population, truncated 25-64)...
[Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity]Renzo Volante
CPO Piemonte, Torino
Epidemiol Prev 36:78-86. 2012..1% of those with known treatment). However, 0.7% of all CIN2 and 1.7% of all CIN3 had hysterectomy. Among the 151 women with invasive carcinoma, 10.6% plausibly with microinvasive disease, only one treatment LLETZ is reported...
Effect of circulation and discussion of cervical smears on agreement between laboratoriesG Ronco
Centre for Cancer Epidemiology and Prevention in Piedmont CPO, Torino, Italy
Cytopathology 14:115-20. 2003..Overall, the intervention increased diagnostic agreement, but its effect varied with laboratory and by diagnostic class and could be transient. Continued programmes of smear exchange and discussion appear to be advisable...
Process performance of cervical screening programmes in EuropeGuglielmo Ronco
Unit of Cancer Epidemiology, Centre for Cancer Prevention, via San Francesco da Paola 31, 1023 Torino, Italy
Eur J Cancer 45:2659-70. 2009..Nevertheless, there is a clear need to standardise the cytological and histological classifications used in screening, as well as data registration systems across Europe...
New paradigms in cervical cancer prevention: opportunities and risksGuglielmo Ronco
Unità di epidemiologia dei tumori, CPO Piemonte, Torino, Italy
BMC Womens Health 8:23. 2008..Research on how to best screen vaccinated women is a priority. This paper proposes an overview of the plausible impact of new technologies in cervical cancer screening in the near future and in the vaccinated cohorts...
[Epidemiology of HPV genital infection and of its complications and use of HPV testing for cervical cancer screening]Guglielmo Ronco
, CPO Piemonte
Epidemiol Prev 31:86-91. 2007
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening testGuglielmo Ronco
Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica, Turin, Italy
J Natl Cancer Inst 100:492-501. 2008..HPV-positive women were directly referred to colposcopy if aged 35 or older; if younger, they were retested after 1 year...
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytologyGuglielmo Ronco
Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica CPO, Via S Francesco da Paola 31, 10123 Turin, Italy
Eur J Cancer 43:476-80. 2007..5% (95%CI 58.3-70.3) at age 35-60. In conclusion, triaging by HPV testing performed better in women aged over 35 years than those younger. For older women, HPV triaging should also be considered for managing those with LSIL cytology...
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialGuglielmo Ronco
Unit of Cancer Epidemiology, Centre for Cancer Prevention, Via S Francesco da Paola 31 10123 Turin, Italy
BMJ 335:28. 2007..To compare the accuracy of conventional cytology with liquid based cytology for primary screening of cervical cancer...
HPV testing for primary cervical cancer screeningGuglielmo Ronco
Unit of Cancer Epidemiology, CPO Piemonte, Torino 10123, Italy
Lancet 370:1740-2. 2007
The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitmentGuglielmo Ronco
Centro per la Prevenzione Oncologica CPO, Torino, Italy
Gynecol Oncol 107:S230-2. 2007..To study the impact of different cervical cancer screening strategies including HPV testing...
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trialGuglielmo Ronco
Centre for Cancer Prevention CPO, Turin, Italy
Lancet Oncol 7:547-55. 2006..We aimed to compare conventional screening with an experimental strategy in women aged 25-34 years, and investigate the effect of different criteria of referral to define the best methods of HPV screening...
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trialGuglielmo Ronco
Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica Piemonte, 10123 Turin, Italy
J Natl Cancer Inst 98:765-74. 2006....
Cervical cancer screening in Italy: quality of colposcopy and treatment. 2009 activityGuglielmo Ronco
CPO Piemonte, Torino
Epidemiol Prev 35:78-86. 2011..6% of those with known treatment). However 0.4% of all CIN2 and 3.6% of all CIN3 had hysterectomy. Among the 199 women with invasive carcinoma, 12% plausibly with microinvasive disease had only excisional treatment reported...
Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosisGuglielmo Ronco
Centro per la Prevenzione Oncologica del Piemonte CPO, Turin, Italy
Cancer 99:83-8. 2003..For smears indicated to require further review, the system provides maps (PapMaps) to identify the most abnormal areas of the smear...
Prevalence of human papillomavirus infection in women in Turin, ItalyGuglielmo Ronco
Unit of Cancer Epidemiology, CPO Piemonte, ASO S Giovanni Battista, via San Francesco da Paola 31, 10123 Turin, Italy
Eur J Cancer 41:297-305. 2005..In conclusion, overall, the female population of Turin showed an HPV prevalence that is intermediate compared with worldwide levels...
Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98G Ronco
Unit of Cancer Epidemiology, Centre for cancer Epidemiology and Prevention CPO Piemonte, via San Francesco da Paola 31, 10123 Torino, Italy
Br J Cancer 93:376-8. 2005..25 (95% CI 0.13-0.50) for attenders vs non attenders. An organised screening programme can further reduce cervical cancer incidence in an area where substantial spontaneous activity was previously present...
Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activityGuglielmo Ronco
CPO Piemonte, Torino
Epidemiol Prev 35:39-54. 2011..2%. The unadjusted detection rate of CIN2 or more severe histology was 3.2 per 1,000 screened women (3.2 standardised on the Italian population, truncated 25-64)...
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialGuglielmo Ronco
Centre for Cancer Prevention, Turin, Italy
Lancet Oncol 11:249-57. 2010..We assessed the efficacy of cervical-cancer screening policies that are based on HPV testing...
A first survey of organized cervical cancer screening programs in Italy. GISCi working group on organization and evaluation. Gruppo Italiano Screening CitologicoG Ronco
Department of Oncology, ASL TOI, Center for Cancer Epidemiology and Prevention (CPO, Regione Piemonte, Torino, Italy
Tumori 84:624-30. 1998..01%. A need for improvement in the process of evaluation and for homogenization of criteria of cytology interpretation was identified: work in this regard is on-going...
Extension of organised cervical cancer screening programmes in Italy and their process indicatorsGuglielmo Ronco
CPO Piemonte, Torino
Epidemiol Prev 31:33-47. 2007..The unadjusted detection rate ofhistologically confirmed CIN2 or more severe was 2.7 per 1000 screened women (3.0 per 1000, standardised on the Italian population, truncated 25-64)...
Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategiesN Segnan
C.P.O. Piemonte, Dipartimento di Oncologia, Ospedale S. Giovanni AS, Azienda USLI, Torino, Italy
Tumori 84:348-53. 1998..Efficiency can be ensured through the adoption of overbooking, provided that attendance levels are regularly monitored...
Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?P Armaroli
SCDO Epidemiologia dei Tumori, Centro Prevenzione Oncologica Regione Piemonte and Azienda Ospedaliero Universitaria S Giovanni Battista di Torino, V San Francesco da Paola 31, Torino 10123, Italy
Br J Cancer 99:239-44. 2008..23, 95% CI: 0.00-0.46). Over 50 years of age, after four tests at least three false-positive cases are diagnosed for every true positive. Benefits arising from cytological screening is uncertain in well-screened older women...
Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activityRenza Volante
OIRM S Anna, Torino, Italy
Epidemiol Prev 33:75-82. 2009..9% of those with known treatment). However 0.7% of all CIN2 and 3.4% of all CIN3 had hysterectomy. Among the 100 women with invasive carcinoma, 17% (plausibly with microinvasive disease) had only excisional treatment reported...
Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencingLaura De Marco
Unit of Cancer Epidemiology, C E R M S, University of Turin, Via Santena 7, 10126 Turin, Italy
J Clin Virol 38:7-13. 2007..HPV16 is the prevalent HR-type worldwide associated to cervical cancer. Integration of viral DNA promotes a selective cell growth advantage, resulting a risk factor for cancer development...
Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patientsM Preti
Department of Gynecology and Obstetrics, University of Turin, Turin, Italy
Cancer 88:1869-76. 2000..The identification of prognostic factors in the recurrence of vulvar squamous cell carcinoma is crucial for less invasive treatments...
Assessment of specimen adequacy reproducibility: an Italian experienceGioia Montanari
Prevenzione Serena, CPO Piemonte, Torino, Italy
Diagn Cytopathol 28:224-6. 2003..New Italian guidelines on adequacy proposed the GISCi are presented and the recommendation is made to eliminate the SBLB category...
Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kitsAnna Gillio-Tos
Unit of Cancer Epidemiology, C E R M S, University of Turin, Via Santena 7, 10126 Turin, Italy
J Clin Virol 36:126-32. 2006..Infection with human papillomavirus (HPV) is a necessary step in the progression to cervical cancer. Many methods for HPV testing are currently available, most developed to detect pools of HPV types...
Extension of organised cervical cancer screening programmes in Italy and their process indicatorsGuglielmo Ronco
CPO Piemonte, Torino
Epidemiol Prev 32:37-54. 2008..The unadjusted detection rate of histologically confirmed CIN2 or more severe was 2.7 per 1,000 screened women (2.6 standardised on the Italian population, truncated 25-64)...
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screeningPhilip Davies
European Cervical Cancer Association, 68 cours Albert Thomas, Lyon, France
Int J Cancer 118:791-6. 2006..Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test...
The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspectivePaolo Giorgi-Rossi
Agency for Public Health, Lazio Region, Rome, Italy
Int J Cancer 121:2729-34. 2007..If HPV testing is applied with cytology-triage, a single HPV test may cost 20-30% more than a conventional Pap to result in the same overall cost per CIN2+ detected...
Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening SettingFrancesca Maria Carozzi
Center for Study and Prevention of Cancer (CSPO, Florence, Italy
Am J Clin Pathol 124:716-21. 2005..91, 0.60, and 0.69 with PreservCyt and 0.93, 0.87, and 0.90 with STM. Our data showed high reliability and reproducibility with HC2, with values higher for STM than ThinPrep (Cytyc) samples...
Activity level and process indicators of organised programmes for cervical cancer screening in ItalyGuglielmo Ronco
Centro Prevenzione Oncologica, Torino
Epidemiol Prev 30:27-40. 2006..Despite this rise, quality indicators were stable. However, in a few programmes, the use of excessively broad criteria in the interpretation of cytology decides an excessively high rate of referrals to colposcopy...
National survey of the quality of 2nd level in screening for cervical cancerRenza Volante
Azienda Ospedaliera O.I.R.M. Sant'Anna, Torino
Epidemiol Prev 30:51-7. 2006..Some 0.7% of all CIN2 and 5.1% of all CIN3 had hysterectomy. Some 12% of the 111 invasive carcinoma, plausibly microinvasive, had excisional treatment only...
Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmesRenza Volante
OIRM S Anna, Torino
Epidemiol Prev 32:69-76. 2008..6% of those with known treatment). However, 1.5 % of all CIN2 and 5.5 % of all CIN3 had hysterectomy. Among the 140 women with invasive carcinoma 17.8%, plausibly with microinvasive disease, had excisional treatment only reported...
Chapter 10: New dimensions in cervical cancer screeningJack Cuzick
Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London, United Kingdom
Vaccine 24:S3/90-7. 2006..The fact that HPV is a sexually transmitted infection may lead to anxiety and concerns about sexual relationships and these issues are also discussed. Ongoing HPV studies are identified and briefly reviewed...
Variations in the age-specific curves of human papillomavirus prevalence in women worldwideSilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Int J Cancer 119:2677-84. 2006..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveysSalvatore Vaccarella
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 15:2148-53. 2006....
The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histologic lesions found in the NTCC trialPaolo Dalla Palma
Pathology Unit, S Chiara Hospital of Trento, Trento, Italy
Am J Clin Pathol 129:75-80. 2008..015). In screening, a low positive predictive value of the colposcopy-referring test may result in unnecessary treatments...
Cervical intraepithelial neoplasia and higher long term risk of cancerGuglielmo Ronco
BMJ 335:1053-4. 2007
Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmesRenza Volante
Azienda Sanitaria Ospedaliera OIRM Sant Anna, Torino
Epidemiol Prev 31:61-8. 2007..However, 0.8% of women with CIN2 and 4.2% of women with CIN3 had hysterectomy. Of the 76 women with invasive carcinoma, 19.8%, plausibly with microinvasive disease, had excisional treatment only reported...
